Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (BEIGF) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for BeOne Medicines (BEIGF) over the last 7 years, with Q3 2025 value amounting to $1.4 billion.

  • BeOne Medicines' Shares Outstanding (Weighted Average) changed N/A to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year change of. This contributed to the annual value of $720.8 million for FY2018, which is 3269.02% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Shares Outstanding (Weighted Average) is $1.4 billion.
  • BeOne Medicines' Shares Outstanding (Weighted Average)'s 5-year high stood at $1.4 billion during Q3 2025, with a 5-year trough of $1.4 billion in Q1 2025.